2004 Recipients
Dr William Kemp
Alfred Hospital, VIC
Role of urotensin II in the control of vascular tone in patients with liver disease
Dr Paul Burgess
Menzies School of Health Research, NT
Evaluation of a community initiated intervention and prevention activity to reduce cardiovascular risk in Indigenous Australians
Dr Gurmeet Singh
Menzies School of Health Research, NT
Risk of heart disease for Aboriginal adolescents.
Dr Alexander Brown
Menzies School of Health Research, NT
Comparison of the quality and outcomes of secondary prevention for Indigenous and non-Indigenous patients after Acute Coronary Syndromes in the Northern
Territory. (Phase II).
Dr Kathleen Potter
Royal Perth Hospital, WA
The Effects of Long-term Treatment with Folic Acid, Vitamin B6 and Vitamin B12 on the Vascular Structure and Function of Stroke Patients: A Randomised,
Controlled Trial
Dr Rae-Chi Huang
Royal Perth Hospital, WA
The genetic epidemiology and environmental risk factors in childhood and adolescence
that impact on adult cardiovascular disease risk factors as it manifests phenotypically
as hypertension, insulin resistance, overweight and obesity
Dr Derek Chew
Flinders Medical Centre, SA
Determining the Inflammatory Precipitants of Acute Coronary Syndromes: A cohort-case-crossover
study
Dr Henry Ma
National Stroke Research Institute, VIC
The ischemic penumbra and inflammation: the duration and clinical effect
Dr Jane Prosser
Royal Melbourne Hospital, VIC
The Cardiac and Autonomic Sequelae of Stroke
Dr Yvonne Shen
Prince of Wales Hospital, NSW
Why are people with renal disease insulin resistant?
Dr Danny Liew
Monash University, VIC
Measurement of Serum Brain Natriuretic Peptide in the Australian wide System
of Care paradigm for the management of Chronic Heart Failure – Chronic
Heart-failure Assistance by Telephone (CHAT) Study
Dr Swati Mukherjee
Baker Heart Research Institute, VIC
Relationship if iron, oxidative stress in vivo, nitric oxide bioactivity and
coronary artery disease activity
Dr Georgia Soldatos
Baker Heart Research Institute, VIC
The Role of Advanced Glycation End Products and Oxidative Stress in Diabetic
Cardiovascular Disease.
Dr Christopher Hayward
St Vincent’s Hospital, NSW
Comparison of non-selective and β1-selective β blockers on respiratory
and arterial function and cardiac chamber dynamics in patients with chronic
stable congestive cardiac failure.
Dr Majo Joseph
Flinders Medical Centre, SA
1. Aggressive lipid lowering and its effect on subclinical coronary atherosclerosis:
a high resolution transthoracic echocardiography study.
2. Abnormal left anterior left anterior descending artery wall thickness measurement
by high resolution transthoracic echocardiography: correlation with intravascular
ultrasound and angiographic results.
Dr Christopher Beer
University of Western Australia, WA
Improving patient outcome after acute ischaemic stroke. A placebo-controlled
study to test the effectiveness of atorvastatin and irbesartan in acute ischaemic
stroke
Dr Sharmalar Rajendran
Queen Elizabeth Hospital, SA
Modulation of platelet function by Angiotensin-(1-7) and Angiotensin II : interactions
with angiostensin-converting enzyme inhibitor therapy
Pfizer Australia proudly acknowledges all recipients of Pfizer Australia CVL Research Grants.
Previous Recipients 2003 | 2002 | 2001 | 2000 | 1999
